Pharmacokinetics of the multidrug-resistance-converting drug dexniguldipine and its pyridine metabolite M-1 in the plasma, tumor, and renal tissue of tumor-bearing Wag / Rij rats

[1]  S. Hofer,et al.  Mechanism of action of dexniguldipine-HCl (B8509-035), a new potent modulator of multidrug resistance. , 1995, Biochemical pharmacology.

[2]  D. Kerr,et al.  Quinidine as a resistance modulator of epirubicin in advanced breast cancer: mature results of a placebo-controlled randomized trial. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  A. Eggermont,et al.  Multidrug Resistance in Rat Colon Carcinoma Cell Lines CC531, CC531mdr+ and CC531rev , 1993, Japanese journal of cancer research : Gann.

[4]  B. Sikic.  Modulation of multidrug resistance: at the threshold. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  M. Dietel,et al.  Stereoisomers of calcium antagonists which differ markedly in their potencies as calcium blockers are equally effective in modulating drug transport by P-glycoprotein. , 1992, Biochemical pharmacology.

[6]  H. Grunicke,et al.  B‐859‐35, a new drug with anti‐tumor activity reverses multi‐drug resistance , 1991, International journal of cancer.

[7]  T. Miller,et al.  Systemic toxic effects associated with high-dose verapamil infusion and chemotherapy administration. , 1991, Journal of the National Cancer Institute.

[8]  H. Schuller,et al.  Successful chemotherapy of experimental neuroendocrine lung tumors in hamsters with an antagonist of Ca2+/calmodulin. , 1990, Cancer research.

[9]  I. Pastan,et al.  Multiple-drug resistance in human cancer. , 1987, The New England journal of medicine.

[10]  J. Jeekel,et al.  Interferon treatment of a transplantable rat colon adenocarcinoma: Importance of tumor site , 1984, International journal of cancer.

[11]  B. Sikic,et al.  Pharmacokinetic and Pharmacodynamic Considerations , 2006 .

[12]  I. Youngster,et al.  A Literature Review , 2006 .

[13]  K. Gietzen,et al.  Inhibition of tumour cell growth by a novel dihydropyridine derivative. , 1990, European journal of cancer.